2014
DOI: 10.1158/1078-0432.ccr-13-1664
|View full text |Cite
|
Sign up to set email alerts
|

Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer

Abstract: Purpose Near equal rates of incidence and mortality emphasize the need for novel targeted approaches for better management of pancreatic cancer patients. Inflammatory molecules NFκB and Stat3 are overexpressed in pancreatic tumors. Inhibition of one protein allows cancer cells to survive using the other. The goal of the present study is to determine whether targeting Stat3/NFκB cross talk with a natural product Nexrutine (Nx) can inhibit inflammatory signaling in pancreatic cancer. Experimental design HPNE, … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
79
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
10

Relationship

5
5

Authors

Journals

citations
Cited by 67 publications
(82 citation statements)
references
References 47 publications
(65 reference statements)
3
79
0
Order By: Relevance
“…Interestingly, AG490 and stattic diminished the ACh-induced suppression of NF-κB phosphorylation. Recent studies suggested that JAK2/STAT3 acted as negative regulator of NF-κB activation [38,39]. The potential mechanisms are required to be clarified in the future and dual targets of them has become a significant therapeutic strategy [39].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, AG490 and stattic diminished the ACh-induced suppression of NF-κB phosphorylation. Recent studies suggested that JAK2/STAT3 acted as negative regulator of NF-κB activation [38,39]. The potential mechanisms are required to be clarified in the future and dual targets of them has become a significant therapeutic strategy [39].…”
Section: Discussionmentioning
confidence: 99%
“…Nexrutine R has been tested in our laboratory for many years for its cancer prevention properties in prostate and pancreas models [1621]. Its ability to modulate ROS has only recently been realized [22].…”
Section: Introductionmentioning
confidence: 99%
“…It also has chemotherapeutic potential, and arrests cell cycle progression at the G0/G1 phase in prostate cancer cells [15]. The extract exhibits various biological effects, such as an inhibitory effect on prostatic contractility [49], an anti-osteoarthritic effect [23], an anti-inflammatory property [48], and anticancer activity [16,18,26], but antiangiogenic effects have not been reported yet. This present study aimed to elucidate the effect of the hot water extract of P. amurense on angiogenesis.…”
Section: Discussionmentioning
confidence: 99%